Regencell Bioscience Holdings financial statements

리젠셀 바이오사이언스 홀딩스NASDAQ:RGC · Nasdaq · Healthcare · sector #17
$7.35+1.52%
2026-10-06 close

Regencell Bioscience Holdings's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$4M.

Reported results

Regencell Bioscience Holdings notifications

Quantus Signal · live data · not investment advice · Privacy Policy